发明授权
US07829577B2 Pharmaceutical compositions of (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
有权
(+) - 1,4-二氢-7 - [(3S,4S)-3-甲氧基-4-(甲基氨基)-1-吡咯烷基] -4-氧代-1-(2-噻唑基)-1 ,8-萘啶-3-羧酸
- 专利标题: Pharmaceutical compositions of (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
- 专利标题(中): (+) - 1,4-二氢-7 - [(3S,4S)-3-甲氧基-4-(甲基氨基)-1-吡咯烷基] -4-氧代-1-(2-噻唑基)-1 ,8-萘啶-3-羧酸
-
申请号: US11478765申请日: 2006-06-29
-
公开(公告)号: US07829577B2公开(公告)日: 2010-11-09
- 发明人: Masaru Higaki , Satoshi Nakao
- 申请人: Masaru Higaki , Satoshi Nakao
- 申请人地址: JP US CA So. San Francisco
- 专利权人: Dainippon Sumitomo Pharma Co., Ltd.,Sunesis Pharmaceuticals, Inc.
- 当前专利权人: Dainippon Sumitomo Pharma Co., Ltd.,Sunesis Pharmaceuticals, Inc.
- 当前专利权人地址: JP US CA So. San Francisco
- 代理机构: Jones Day
- 主分类号: A61K31/47
- IPC分类号: A61K31/47
摘要:
The present invention relates to SNS-595 and methods of treating cancer using the same.
公开/授权文献
- US20060247267A1 SNS-595 and methods of using the same 公开/授权日:2006-11-02
信息查询